Drug Eluting Balloon
B. Braun Vascular Systems presents a Drug Eluting Balloon for PTCA, based on a polymer-free carrier matrix. This most innovative product is the result of our sustained research for new options and improvements in the field of coronary angioplasty. Clinically proven, it offers completely new procedural options to treat vascular stenoses since the drug elution does not require a stent platform.
Patient Information
“Coronary artery disease and treatment options”
Within the following sites we would like to answer some of your questions on coronary artery disease (CAD), the diagnostic procedure and state of the art treatment options. more
B. Braun – November 2011
Safety and Efficacy: Paclitaxel-Eluting Balloon SeQuent® Please Shows Positive Results in Largest Real World International Registry
The results of the largest registry about treatment with Drug Eluting Balloons (DEB) were presented last week during the Transcatheter Cardiovascular Therapeutics conference (TCT) in San Francisco. Primary investigator Prof. Dr. Jochen Woehrle from the University of Ulm explained: “The aim of the SeQuent Please World Wide Registry is to assess the safety and efficacy of the paclitaxel-coated SeQuent Please treatment of patients under so called real world conditions for multiple indications.” more as PDF Download
